Topotecan Plus Cytarabine Is an Effective and Safe Regimen for Newly Diagnosed and Adverse ELN-Risk Acute Myeloid Leukemia Subset in Patients with Cardiac Comorbidities

Clémence Marcault; Geoffroy Venton; Lauris Gastaud; Lionel Mannone; Jérôme Rey; Evelyne D’Incan; Colombe Saillard; Aude Charbonnier; Sophie Raynaud; Norbert Vey

doi:10.1182/blood.v130.suppl_1.2615.2615

Topotecan Plus Cytarabine Is an Effective and Safe Regimen for Newly Diagnosed and Adverse ELN-Risk Acute Myeloid Leukemia Subset in Patients with Cardiac Comorbidities

Identifier:nobleid.org/w1/20260515/D1253FBA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D1253FBA.svg?ark=w1%2F20260515%2FD1253FBA)](https://nobleid.org/work/w1/20260515/D1253FBA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Topotecan Plus Cytarabine Is an Effective and Safe Regimen for Newly Diagnosed and Adverse ELN-Risk Acute Myeloid Leukemia Subset in Patients with Cardiac Comorbidities

Identifier:nobleid.org/w1/20260515/D1253FBA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D1253FBA.svg?ark=w1%2F20260515%2FD1253FBA)](https://nobleid.org/work/w1/20260515/D1253FBA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work